Dolutegravir Sodium
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
1051375-19-9
Chemical name
Dolutegravir Sodium
Molecular formula
C20H18F2N3NaO5
Molecular weight
441.4 g/mol
Synonyms
Dolutegravir sodium salt; TIVICAY PD; JULUCA COMPONENT DOLUTEGRAVIR SODIUM; TRIUMEQ COMPONENT DOLUTEGRAVIR SODIUM; Tivicay; GSK1349572 sodiuM salt; GSK 1349572A; Dovato; GSK1349572 sodium; Dolutegravir sodium [USAN]; Dolutegravir (sodium); Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
InChIKey
UGWJRRXTMKRYNK-VSLILLSYSA-M
PubChem CID
46216142
Signal word
Warning
Catalog reference cue; confirm supplier documentation before use.
Hazard statements
H302, H315, H319, H335
Catalog reference cue; confirm supplier documentation before use.
Physical property reference values are not available in the current MolGraph catalog record.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.